Moderna builds a COVID-19 vaccine production facility in the province of Quebec, Canada

Canadian Prime Minister Justin Trudeau on April 29 announced the pharmaceutical company Moderna will build a COVID-19 vaccine production facility in the country’s province of Quebec to supply up to 100 million doses of the mRNA vaccine annually.

According to the press release, the construction of the facility will begin this year and is expected to be operational in 2024 at the earliest, subject to the approval of plans and regulations in this regard. In addition to the COVID-19 vaccine, the facility is expected to be able to produce vaccines against other respiratory diseases, such as influenza, while it waits for Moderna to develop a vaccine and get approval from Health Canada.

Regarding the above issue, Canadian Health Minister Jean-Yves Duclos said that the Canadian government will build capacity to produce biomaterials in the country to ensure Canada continues to have access to future vaccines. .

Health Canada approved Moderna’s COVID-19 vaccine Spikevax for adults in the country in December 2020, approved for use in adolescents in August 2021 and for children. from 6 to 11 years old in March this year, with a total of more than 29 million doses of vaccine distributed nationwide. Moderna is currently applying for a license to use another vaccine to protect children aged 6 months to 5 years in Canada. There are currently no vaccines approved for use in children under the age of 5 in this country.

* Invite readers to watch programs broadcast by Vietnam Television on TV Online and VTVGo!